Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
12/2002
12/18/2002EP1266960A1 Method and apparatus for culturing cell or tissue
12/18/2002EP1266227A1 Synergistic activation of regulatory elements by rel proteins and a steroid receptor
12/18/2002EP1266024A1 High fidelity reverse transcriptases and uses thereof
12/18/2002EP1266022A2 Cell-specific adenovirus vectors comprising an internal ribosome entry site
12/18/2002EP1266020A2 Production of foreign polypeptides in plants as viral coat protein fusions
12/18/2002EP1266015A2 Ecdysone receptor-based inducible gene expression system
12/18/2002EP1266014A2 Multifunctional polypeptides comprising a binding site to an epitope of the nkg2d receptor complex
12/18/2002EP1266012A2 Proteases
12/18/2002EP1266011A1 Fungal transcriptional activator useful in methods for producing polypeptides
12/18/2002EP1266010A2 Genetically modified plants and plant cells comprising heterologous heavy metal transport and complexation proteins
12/18/2002EP1266008A2 Acute neuronal induced calcium binding protein type 1 ligand
12/18/2002EP1266007A1 Human survivin interacting protein 1 (sip-1)
12/18/2002EP1266006A2 Production of recombinant blood clotting factors in human cell lines
12/18/2002EP1266005A2 Regulation of human lipoxin a4 receptor-like protein
12/18/2002EP1266003A2 Kcnb: a potassium channel protein
12/18/2002EP1266002A2 Il-17 receptor like molecules and uses thereof
12/18/2002EP1266001A2 Human transcription factors
12/18/2002EP1266000A1 Chordin-like-2 molecules and uses thereof
12/18/2002EP1265999A2 Human schizophrenia gene
12/18/2002EP1265995A2 Method and reagent for the modulation and diagnosis of cd20 and nogo gene expression
12/18/2002EP1265990A2 Renilla reniformis fluorescent proteins, nucleic acids encoding the fluorescent proteins and the use thereof in diagnostics, high throughput screening and novelty items
12/18/2002EP1265989A2 An infective endogenous retrovirus in association with demyelinating diseases e.g. multiple sclerosis
12/18/2002EP1265988A1 Methods for transforming plant plastids and making transplastomic plants
12/18/2002EP1265987A2 Multipotent cell and cardiomyocyte cell populations, and routes to and uses of same
12/18/2002EP1265986A2 Method for in vitro production of three-dimensional vital cartilage or bone tissue and use thereof as transplant material
12/18/2002EP1265985A1 Pancreatic islet cell growth factors
12/18/2002EP1265984A2 In ovo activation of an avian egg in the shell
12/18/2002EP1265926A1 Melanin concentrating hormone receptor chimeric and fusion proteins
12/18/2002EP1265924A2 Il-17 receptor like molecules and uses thereof
12/18/2002EP1265920A2 Angiogenesis-associated proteins, and nucleic acids encoding the same
12/18/2002EP1265919A2 G-protein associated molecules
12/18/2002EP1265918A1 Human immune response proteins
12/18/2002EP1265916A2 Therapeutic anti-cytomegalovirus compounds
12/18/2002EP1265915A2 Novel compounds
12/18/2002EP1265914A2 Wnt-1 related polypeptides, and nucleic acids encoding the same
12/18/2002EP1265910A2 Nucleic acids, proteins, and antibodies
12/18/2002EP1265648A1 Novel natural polymer-based material with improved properties for use in human and veterinary medicine and the method of manufacturing such
12/18/2002EP1265627A2 Methods and compositions for inhibiting angiogenesis
12/18/2002EP1265624A1 Mycobacterium ag85 complex-specific t cell peptides and use in diagnostic and therapeutic applications thereof
12/18/2002EP1265479A1 Methods for gamete production in birds
12/18/2002EP1030922A4 $i(dull1) CODING FOR A STARCH SYNTHASE AND USES THEREOF
12/18/2002EP0946721B1 Human growth gene and short stature gene region
12/18/2002EP0930887B1 Cancer immunotherapy using tumor cells combined with mixed lymphocytes
12/18/2002EP0925370B1 Biochemical analysis of antioxidant function
12/18/2002EP0904296B1 Monoclonal antibody that detects apoptotic antigen
12/18/2002EP0876478A4 Monoclonal antibody to herpes simplex virus and cell line producing same
12/18/2002EP0805852B1 Methods for producing cytoplasmic male sterility in plants and use thereof in production of hybrid seed
12/18/2002EP0789583B1 Methods and kits using macrophage stimulating protein
12/18/2002EP0736002B9 Compound capable of introducing at least one molecule into a cell
12/18/2002EP0726944B1 Glycosylated and non-glycosylated bactericidal/permeability increasing proteins, and methods for producing same
12/18/2002EP0668930B1 A method of identifying ligands and antagonists of ligands
12/18/2002EP0662150B1 Maspin, a novel serpin with tumor suppressing activity
12/18/2002EP0641385B1 Development of dna probes and immunological reagents of human tumor associated antigens
12/18/2002EP0555370B1 Methods and applications for efficient genetic suppressor elements
12/18/2002CN1385532A Expression system utilizing self-schizolysis fusing protein and novel reduction polypeptide
12/18/2002CN1385529A Expression system utilizing self-schizolysis fusing protein and novel reduction polypeptide
12/18/2002CN1385523A Application of human mature follicle fluid in external mature technology of immature ovum
12/17/2002US6495741 Method of selecting transformed Brassica tissue
12/17/2002US6495740 Manipulation of cellulose and/or β-1,4-Glucan
12/17/2002US6495739 Plant phosphatidic acid phosphatases
12/17/2002US6495738 Aspergillus; genetic engineering
12/17/2002US6495736 Compositions and methods for increasing bone mineralization
12/17/2002US6495735 Transgenic non-human mammals expressing DNA sequences encoding homologous complement restriction factors of a discordant mammalian species
12/17/2002US6495675 Pharmaceutical composition for treating or preventing influenza, and novel capped oligonucleotide
12/17/2002US6495666 Polypeptide composing human chimeric antibody
12/17/2002US6495665 Isoforms of mouse serotonin 5-HT2C receptor
12/17/2002US6495662 Bioactive peptides and peptide derivatives of parathyroid hormone (PTH) and parathyroid hormone-related peptide (PTHrP)
12/17/2002US6495519 Interleukin-1 β converting enzyme like apoptosis protease-3 and 4
12/17/2002US6495376 Phosphoserine and phosphothreonine binding modules. the ww-domain containing polypeptides of the invention can be used, for example, to regulate cell growth; to treat neurodegenerative diseases; to screen for substances that
12/17/2002US6495365 Hematopoietic stem cell proliferating agents
12/17/2002US6495361 Method of producing infectious papillomavirus in placental cells
12/17/2002US6495360 Increasing production yield of viruses, viral proteins, and other related biological materials through enhanced control and stabilization of protein production via stress proteins; permissive eukaryotic cell lines
12/17/2002US6495359 Sphingosine-1-phosphate lyase polypeptides, polynucleotides and modulating agents and methods of use therefor
12/17/2002US6495354 Synthases
12/17/2002US6495346 Do not react with foreign partners; amino acids inserted into proteins which naturally form dimers, mutated proteins only form complexes with themselves (homodimers) or with the mutated partner (heterodimers), not with nonmutated starting
12/17/2002US6495344 Useful in the nutrition of patients suffering from phenylketonuria
12/17/2002US6495331 Regulation of cytokine production such that allergic inflammation is thereby treated by administering a compound which interacts with mekk/jnkk signal transduction pathway
12/17/2002US6495316 Cells suitable for the detection of herpes virus, wherein said cells comprise mrc-5 cells and cv-1 cells
12/17/2002US6495135 Immortalized human keratinocyte cell line
12/17/2002US6495128 Human chemokine β-7 deletion and substitution proteins
12/17/2002CA2214439C A novel growth factor and a genetic sequence encoding same
12/17/2002CA2080260C Monoclonal antibodies against tumor-associated antigens, processes for the preparation thereof and the use thereof
12/12/2002WO2002099427A1 Srpks as modifiers of the p53 pathway and methods of use
12/12/2002WO2002099426A1 Pecis as modifiers of the p53 pathway and methods of use
12/12/2002WO2002099383A2 Compositions and methods for evaluating viral receptor/co-receptor usage and inhibitors of virus entry using recombinant virus assays
12/12/2002WO2002099140A1 GLRAs AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE
12/12/2002WO2002099138A2 HS2STs AS MODIFIERS OF THE P53 PATHWAY AND METHODS OF USE
12/12/2002WO2002099131A1 Transcription factor binding element
12/12/2002WO2002099125A1 PIBs AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE
12/12/2002WO2002099122A1 Modifiers of the p53 pathway and methods of use
12/12/2002WO2002099120A2 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof
12/12/2002WO2002099117A2 Nucleic acid regulatory sequences and uses therefor
12/12/2002WO2002099115A2 Nucleic acid-associated proteins
12/12/2002WO2002099108A2 Atp-binding cassette transporter-like molecules and uses thereof
12/12/2002WO2002099102A1 Numb protein expression inhibitors by musashi
12/12/2002WO2002099101A1 Molecular clones with mutated hiv gag/pol, siv gag and siv env genes
12/12/2002WO2002099100A2 Method of production of a protein in cells which inducibly express the cell cycle inhibitor protein, p21
12/12/2002WO2002099097A1 Novel compounds for chemiluminescense procedures
12/12/2002WO2002099095A2 Improved isoprenoid production
12/12/2002WO2002099089A1 Compositions and methods for high-level, large-scale production of recombinant proteins